Enzymatica Publ (Sweden) Today
| ENZY Stock | SEK 3.53 0.09 2.62% |
Performance2 of 100
| Odds Of DistressLess than 44
|
Enzymatica Publ is selling for under 3.53 as of the 24th of April 2024; that is 2.62% increase since the beginning of the trading day. The stock's last reported lowest price was 3.35. Enzymatica Publ has about a 44 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Enzymatica publ AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. Enzymatica AB was incorporated in 2007 and is based in Lund, Sweden. Enzymatica operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 164.26 M outstanding shares. More on Enzymatica publ AB
Moving against Enzymatica Stock
| 0.67 | SSAB-B | SSAB AB | PairCorr |
Enzymatica Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Enzymatica Publ's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Enzymatica Publ or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chief Executive Officer | Fredrik Lindberg |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Enzymatica publ AB (ENZY) is traded on Stockholm Exchange in Sweden and employs 23 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 681.8 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enzymatica Publ's market, we take the total number of its shares issued and multiply it by Enzymatica Publ's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Enzymatica publ AB operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 164.26 M outstanding shares.
Enzymatica publ AB has accumulated about 64.82 M in cash with (35.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Check Enzymatica Publ Probability Of Bankruptcy
Ownership AllocationEnzymatica publ AB retains a total of 164.26 Million outstanding shares. Enzymatica publ AB shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.15 percent of Enzymatica publ AB outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Enzymatica Ownership Details
Enzymatica Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Enzymatica Publ jumping above the current price in 90 days from now is about 14.79%. The Enzymatica publ AB probability density function shows the probability of Enzymatica Publ stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Enzymatica Publ has a beta of 0.5216 suggesting as returns on the market go up, Enzymatica Publ average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Enzymatica publ AB will be expected to be much smaller as well. Additionally, enzymatica publ AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Enzymatica Publ to move above the current price in 90 days from now is about 14.79 (This Enzymatica publ AB probability density function shows the probability of Enzymatica Stock to fall within a particular range of prices over 90 days) .
Enzymatica publ AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Enzymatica Publ market risk premium is the additional return an investor will receive from holding Enzymatica Publ long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Enzymatica Publ. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Enzymatica Publ's alpha and beta are two of the key measurements used to evaluate Enzymatica Publ's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.74 | |||
| Standard Deviation | 3.42 | |||
| Variance | 11.67 | |||
| Risk Adjusted Performance | 0.0076 |
Enzymatica Stock Against Markets
Picking the right benchmark for Enzymatica Publ stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Enzymatica Publ stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Enzymatica Publ is critical whether you are bullish or bearish towards Enzymatica publ AB at a given time. Please also check how Enzymatica Publ's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Enzymatica Publ without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Enzymatica Publ Corporate Directors
Enzymatica Publ corporate directors refer to members of an Enzymatica Publ board of directors. The board of directors generally takes responsibility for the Enzymatica Publ's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Enzymatica Publ's board members must vote for the resolution. The Enzymatica Publ board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jonas Forsberg | Director | Profile | |
| Anders Jungbeck | Director | Profile | |
| Nils Siegbahn | Director | Profile | |
| Sigurgeir Gudlaugsson | Director | Profile |
How to buy Enzymatica Stock?
Before investing in Enzymatica Publ, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Enzymatica Publ. To buy Enzymatica Publ stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Enzymatica Publ. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Enzymatica Publ stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Enzymatica publ AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Enzymatica publ AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Enzymatica publ AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Enzymatica publ AB?
The danger of trading Enzymatica publ AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Enzymatica Publ is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Enzymatica Publ. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Enzymatica publ AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzymatica publ AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Enzymatica Stock analysis
When running Enzymatica Publ's price analysis, check to measure Enzymatica Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzymatica Publ is operating at the current time. Most of Enzymatica Publ's value examination focuses on studying past and present price action to predict the probability of Enzymatica Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzymatica Publ's price. Additionally, you may evaluate how the addition of Enzymatica Publ to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |